Stoke Therapeutics, Inc. · NASDAQ:STOK
BVF PARTNERS L P/IL reported a 5.60% stake in Stoke Therapeutics, Inc. (Schedule 13G)
Event Sep 23, 2026 · Filed Sep 30, 2026
BVF PARTNERS L P/IL reported a 5.60% stake in Stoke Therapeutics, Inc., 3,608,968 shares, as a passive investor on Sep 23, 2026. Filed Sep 30, 2026 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 3,608,968
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.90% | 1,866,761 |
| BVF I GP LLC | 2.90% | 1,866,761 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.20% | 1,404,263 |
| BVF II GP LLC | 2.20% | 1,404,263 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 261,006 |
| BVF Partners OS Ltd. | 0.40% | 261,006 |
| BVF GP HOLDINGS LLC | 5.10% | 3,271,024 |
| BVF PARTNERS L P/IL | 5.60% | 3,608,968 |
| BVF INC/IL | 5.60% | 3,608,968 |
| LAMPERT MARK N | 5.60% | 3,608,968 |